Submit Your Abstract by December 31
|Submit Your Abstract|
Share your research with an audience of your peers and discover new opportunities for collaboration by submitting an abstract for Translational Science 2018! This is an excellent opportunity to show your colleagues what you have been working on. Abstracts can be evaluated for both poster and distinguished oral abstract presentations based on your preference. Please note that you must register for Translational Science 2018 in order for your abstract to be accepted.
- November 15: Call for Abstracts opens
- December 31: Call for Abstracts closes
- Early February: All individuals will be notified of their acceptance status
Abstracts submitted for Translational Science 2018 may represent work in progress or previously published research. If you wish your abstract to be considered for publication, it must be original research not published previously and not being considered for publication elsewhere. Edits to abstracts may be made up until submissions close.
All abstracts require the following pieces of information:
- Title (255 character limit, including spaces)
- Research overview (1500 characters limit, including spaces)
- Methods/Study Population
- Results/Anticipated Results
- Discussion/Significance of Impact
- If funded, grant numbers or other funding source
- Authors' Conflict of Interest
Abstracts must align with Translational Science's abstract tracks.
- Basic/Translational Science
- Clinical Epidemiology / Clinical Trial
- Biomedical Informatics / Health Informatics / Digital Health / Social Media
- Education/Mentoring / Professional and Career Development
- Science and Health Policy / Ethics / Health Impacts / Outcomes Research
- Health Equity / Community Engagement
Submitted abstracts may also be published in the Journal of Clinical and Translational Science and must adhere to the following guidelines:
- A submitted abstract must be an original contribution and may not be under consideration for publication elsewhere.
- Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and reviewers make every effort to ensure the validity of published abstracts, the final responsibility rests with the authors and not with the ACTS, AFMR, CR Forum, or the Journal of Clinical and Translational Science.
- Additional information regarding the publication of manuscripts in the Journal of Clinical and Translational Science can be found at the Cambridge University Press.
Burroughs Wellcome Fund Travel Award
Since 2009, the Burroughs Wellcome Fund has generously supported early career scholars and pre-doctoral trainees to take part in the Translational Science Annual Meeting. This grant is intended to support trainee travel to Translational Science 2018, April 19-21 in Washington, DC.
The Burroughs-Wellcome Fund is an independent private foundation dedicated to advancing the biomedical sciences by supporting research and other scientific and educational activities. Within this broad mission, BWF has two primary goals:
- To help scientists early in their careers develop as independent investigators
- To advance fields in the basic biomedical sciences that are undervalued or in need of particular encouragement
BWF’s financial support is channeled primarily through competitive, peer-reviewed award programs.
In order to be considered for a BWF Award, the primary author must be a trainee and upload a CV during the abstract submission process. Applicants that are not trainees or applications without CVs will not be considered. To apply, select the option for Burroughs Wellcome during the abstract submission process.
If you have any questions about the abstract submission process, please email firstname.lastname@example.org.